BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE

BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE was reported 97871 times

These side effects are most commonly reported by patients taking BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE:

# Side effect Count
0 DYSPNOEA 17904
1 ASTHMA 12227
2 COUGH 8045
3 DRUG INEFFECTIVE 6922
4 OFF LABEL USE 5977
5 PNEUMONIA 5945
6 WHEEZING 5768
7 FATIGUE 5483
8 MALAISE 4658
9 HEADACHE 4655
10 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4067
11 NAUSEA 4063
12 DEATH 3844
13 DRUG DOSE OMISSION 3643
14 INTENTIONAL PRODUCT MISUSE 3558
15 PAIN 3370
16 DIZZINESS 3365
17 DIARRHOEA 3218
18 CHEST DISCOMFORT 3084
19 PRODUCT DOSE OMISSION ISSUE 3010
20 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2978
21 WEIGHT DECREASED 2900
22 NASOPHARYNGITIS 2836
23 DEVICE MALFUNCTION 2806
24 PRODUCTIVE COUGH 2730
25 ARTHRALGIA 2632
26 ASTHENIA 2624
27 FALL 2603
28 VOMITING 2486
29 BRONCHITIS 2372
30 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2351
31 PRODUCT USE ISSUE 2274
32 PYREXIA 2269
33 WEIGHT INCREASED 2256
34 CONDITION AGGRAVATED 2255
35 SINUSITIS 2239
36 HYPERTENSION 2195
37 ANXIETY 2170
38 RASH 2170
39 DYSPHONIA 2102
40 CHEST PAIN 2085
41 PRURITUS 2071
42 INSOMNIA 2059
43 FEELING ABNORMAL 2030
44 PAIN IN EXTREMITY 1988
45 OBSTRUCTIVE AIRWAYS DISORDER 1978
46 BACK PAIN 1924
47 HYPERSENSITIVITY 1828
48 OROPHARYNGEAL PAIN 1817
49 BLOOD PRESSURE INCREASED 1798
50 INFLUENZA 1777
51 PRODUCT QUALITY ISSUE 1753
52 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1698
53 GASTROOESOPHAGEAL REFLUX DISEASE 1637
54 DYSPNOEA EXERTIONAL 1611
55 MUSCLE SPASMS 1610
56 NASAL CONGESTION 1589
57 DEVICE ISSUE 1542
58 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1523
59 TREMOR 1482
60 COVID-19 1472
61 PRODUCT USE IN UNAPPROVED INDICATION 1467
62 DEPRESSION 1465
63 GAIT DISTURBANCE 1444
64 LUNG DISORDER 1443
65 DEVICE DELIVERY SYSTEM ISSUE 1420
66 INCORRECT DOSE ADMINISTERED 1396
67 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1389
68 HEART RATE INCREASED 1361
69 ABDOMINAL PAIN 1309
70 INTENTIONAL DEVICE MISUSE 1305
71 PERIPHERAL SWELLING 1291
72 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1281
73 URTICARIA 1274
74 DECREASED APPETITE 1256
75 DRUG HYPERSENSITIVITY 1255
76 VISUAL IMPAIRMENT 1231
77 MEMORY IMPAIRMENT 1230
78 LOWER RESPIRATORY TRACT INFECTION 1224
79 DEVICE USE ISSUE 1206
80 FULL BLOOD COUNT ABNORMAL 1205
81 OXYGEN SATURATION DECREASED 1203
82 OEDEMA PERIPHERAL 1188
83 RHINORRHOEA 1173
84 ILLNESS 1172
85 ABDOMINAL PAIN UPPER 1167
86 URINARY TRACT INFECTION 1153
87 CONSTIPATION 1135
88 MYALGIA 1122
89 INFECTION 1106
90 BLOOD COUNT ABNORMAL 1086
91 ACUTE KIDNEY INJURY 1065
92 PALPITATIONS 1003
93 THROAT IRRITATION 1000
94 MYOCARDIAL INFARCTION 994
95 INJECTION SITE PAIN 993
96 VISION BLURRED 991
97 HYPOTENSION 985
98 PRODUCT DOSE OMISSION 972
99 SPUTUM DISCOLOURED 967
100 ATRIAL FIBRILLATION 966
101 CATARACT 966
102 UPPER RESPIRATORY TRACT INFECTION 962
103 ABDOMINAL DISCOMFORT 960
104 ERYTHEMA 959
105 SOMNOLENCE 956
106 CONTUSION 952
107 HOSPITALISATION 951
108 HYPOAESTHESIA 949
109 RENAL FAILURE 944
110 PARAESTHESIA 928
111 ANAEMIA 914
112 CHRONIC KIDNEY DISEASE 906
113 CARDIAC DISORDER 890
114 CHILLS 862
115 CEREBROVASCULAR ACCIDENT 859
116 RESPIRATORY DISORDER 854
117 ARTHRITIS 852
118 DIABETES MELLITUS 851
119 CONFUSIONAL STATE 838
120 SLEEP DISORDER 823
121 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 822
122 DRY MOUTH 821
123 INCORRECT DOSE ADMINISTERED BY DEVICE 819
124 DYSPEPSIA 793
125 LOSS OF CONSCIOUSNESS 787
126 ALOPECIA 769
127 CARDIAC FAILURE CONGESTIVE 749
128 MIGRAINE 739
129 DEVICE FAILURE 731
130 RESPIRATORY TRACT INFECTION 728
131 STRESS 706
132 GENERAL PHYSICAL HEALTH DETERIORATION 701
133 DEHYDRATION 700
134 MIDDLE INSOMNIA 691
135 INTENTIONAL PRODUCT USE ISSUE 687
136 DRUG DOSE OMISSION BY DEVICE 672
137 MUSCULAR WEAKNESS 669
138 SLEEP APNOEA SYNDROME 667
139 ABDOMINAL DISTENSION 657
140 JOINT SWELLING 657
141 EMPHYSEMA 654
142 HYPERHIDROSIS 650
143 NERVOUSNESS 639
144 RESPIRATORY FAILURE 638
145 PULMONARY EMBOLISM 637
146 HAEMOPTYSIS 634
147 TACHYCARDIA 633
148 SYNCOPE 625
149 SWELLING 614
150 BODY HEIGHT DECREASED 610
151 DYSPHAGIA 610
152 OSTEOPOROSIS 607
153 SEASONAL ALLERGY 601
154 DYSGEUSIA 596
155 EPISTAXIS 589
156 RESPIRATORY TRACT CONGESTION 588
157 FORCED EXPIRATORY VOLUME DECREASED 581
158 LUNG NEOPLASM MALIGNANT 580
159 DRUG INTERACTION 578
160 VIRAL INFECTION 566
161 BLOOD PRESSURE DECREASED 565
162 BLOOD PRESSURE SYSTOLIC INCREASED 562
163 EOSINOPHIL COUNT INCREASED 562
164 SINUS DISORDER 560
165 BRONCHIECTASIS 556
166 SECRETION DISCHARGE 552
167 APHONIA 550
168 BLOOD GLUCOSE INCREASED 545
169 ANAPHYLACTIC REACTION 544
170 CANDIDA INFECTION 536
171 CARDIAC FAILURE 535
172 SEPSIS 531
173 ECZEMA 510
174 HYPOACUSIS 503
175 INFLUENZA LIKE ILLNESS 503
176 BALANCE DISORDER 500
177 HERPES ZOSTER 500
178 RHEUMATOID ARTHRITIS 495
179 NEUROPATHY PERIPHERAL 494
180 SWELLING FACE 493
181 CELLULITIS 490
182 PULMONARY MASS 490
183 UPPER-AIRWAY COUGH SYNDROME 490
184 EOSINOPHILIA 489
185 ILL-DEFINED DISORDER 489
186 DISCOMFORT 484
187 HYPOXIA 482
188 OVERDOSE 482
189 ADVERSE EVENT 480
190 BREATH SOUNDS ABNORMAL 478
191 HAEMOGLOBIN DECREASED 478
192 NO ADVERSE EVENT 478
193 DRY SKIN 477
194 LUNG INFECTION 474
195 GASTROINTESTINAL HAEMORRHAGE 471
196 PULMONARY CONGESTION 471
197 THROMBOSIS 465
198 PLEURAL EFFUSION 461
199 GASTROINTESTINAL DISORDER 459
200 INTENTIONAL DRUG MISUSE 459
201 MUSCULOSKELETAL STIFFNESS 457
202 SPEECH DISORDER 453
203 MUSCULOSKELETAL PAIN 450
204 ADVERSE DRUG REACTION 449
205 ASTHMATIC CRISIS 449
206 BURNING SENSATION 449
207 MOBILITY DECREASED 448
208 HAEMORRHAGE 446
209 NECK PAIN 446
210 SEIZURE 440
211 FLUSHING 432
212 OEDEMA 431
213 AMNESIA 430
214 BRONCHOSPASM 429
215 OSTEOARTHRITIS 421
216 DEVICE DEFECTIVE 414
217 FLUID RETENTION 414
218 EYE DISORDER 412
219 VERTIGO 411
220 PSORIASIS 409
221 NEOPLASM MALIGNANT 403
222 NASAL POLYPS 400
223 EYE PAIN 395
224 PULMONARY OEDEMA 394
225 PULMONARY FUNCTION TEST DECREASED 393
226 SNEEZING 393
227 EYE PRURITUS 389
228 EMOTIONAL DISTRESS 387
229 UNDERDOSE 386
230 EAR INFECTION 385
231 BLOOD CHOLESTEROL INCREASED 380
232 ORAL CANDIDIASIS 380
233 TRANSIENT ISCHAEMIC ATTACK 377
234 INJECTION SITE ERYTHEMA 376
235 SUICIDAL IDEATION 376
236 MULTIPLE ALLERGIES 372
237 SINUS CONGESTION 369
238 THERAPEUTIC RESPONSE DECREASED 367
239 BLOOD TEST ABNORMAL 366
240 BLOOD IMMUNOGLOBULIN E INCREASED 365
241 FEELING HOT 364
242 RENAL IMPAIRMENT 363
243 DRUG INTOLERANCE 362
244 HOT FLUSH 362
245 CHOKING 361
246 BONE PAIN 359
247 THROAT TIGHTNESS 358
248 STOMATITIS 356
249 INFLAMMATION 350
250 LACRIMATION INCREASED 349
251 DRY EYE 347
252 AGITATION 344
253 PANIC ATTACK 344
254 TYPE 2 DIABETES MELLITUS 344
255 GLAUCOMA 343
256 INSURANCE ISSUE 343
257 SWOLLEN TONGUE 340
258 RASH PRURITIC 336
259 FLATULENCE 334
260 FUNGAL INFECTION 334
261 SKIN EXFOLIATION 334
262 HYPOTHYROIDISM 332
263 CARDIAC ARREST 330
264 THERAPY CESSATION 328
265 ROAD TRAFFIC ACCIDENT 323
266 HAEMATOCHEZIA 321
267 ARRHYTHMIA 320
268 IMPAIRED QUALITY OF LIFE 320
269 LIP SWELLING 319
270 RENAL DISORDER 319
271 RESPIRATORY DISTRESS 318
272 LIMB INJURY 316
273 PRODUCT TASTE ABNORMAL 316
274 BODY TEMPERATURE DECREASED 315
275 RHINITIS 315
276 NEPHROLITHIASIS 313
277 PRODUCT PACKAGING QUANTITY ISSUE 313
278 INJECTION SITE BRUISING 312
279 EYE SWELLING 311
280 PLATELET COUNT DECREASED 309
281 DEPRESSED MOOD 308
282 HEART RATE DECREASED 307
283 TREATMENT NONCOMPLIANCE 307
284 LYMPHADENOPATHY 306
285 INJECTION SITE PRURITUS 304
286 RIB FRACTURE 303
287 OCULAR HYPERAEMIA 302
288 FIBROMYALGIA 297
289 HYPONATRAEMIA 297
290 RHINITIS ALLERGIC 297
291 DEEP VEIN THROMBOSIS 296
292 DIVERTICULITIS 296
293 LARYNGITIS 296
294 BLOOD POTASSIUM DECREASED 294
295 MEDICATION ERROR 294
296 UNEVALUABLE EVENT 293
297 RECTAL HAEMORRHAGE 292
298 VISUAL ACUITY REDUCED 292
299 LIMB DISCOMFORT 291
300 INFUSION RELATED REACTION 289
301 HALLUCINATION 288
302 CYSTITIS 286
303 INJECTION SITE SWELLING 286
304 PULMONARY FIBROSIS 284
305 THROMBOCYTOPENIA 284
306 SURGERY 282
307 JOINT INJURY 281
308 FEELING JITTERY 280
309 MATERNAL EXPOSURE DURING PREGNANCY 277
310 LETHARGY 276
311 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 270
312 POLLAKIURIA 268
313 RALES 266
314 WHITE BLOOD CELL COUNT INCREASED 266
315 HIP FRACTURE 265
316 RESPIRATION ABNORMAL 264
317 ORAL PAIN 263
318 DRUG EFFECT DECREASED 262
319 EYE IRRITATION 262
320 HEART RATE IRREGULAR 262
321 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 262
322 ARTHROPATHY 261
323 DYSURIA 261
324 IRRITABILITY 261
325 DISTURBANCE IN ATTENTION 259
326 RASH ERYTHEMATOUS 259
327 THERAPY INTERRUPTED 258
328 CROHN^S DISEASE 257
329 DISEASE RECURRENCE 256
330 WHITE BLOOD CELL COUNT DECREASED 256
331 BLOOD PRESSURE FLUCTUATION 255
332 ANGIOEDEMA 254
333 BLOOD CREATININE INCREASED 254
334 HYPOKALAEMIA 253
335 BACTERIAL INFECTION 249
336 CORONARY ARTERY DISEASE 248
337 DISEASE PROGRESSION 248
338 HEPATIC ENZYME INCREASED 248
339 RESPIRATORY RATE INCREASED 248
340 TINNITUS 248
341 DRY THROAT 247
342 HEAD INJURY 247
343 PNEUMOTHORAX 247
344 SKIN LESION 245
345 STAPHYLOCOCCAL INFECTION 244
346 CHOLELITHIASIS 243
347 LOCALISED INFECTION 243
348 CHRONIC SINUSITIS 240
349 HAEMATOMA 239
350 NEUTROPENIA 239
351 AGEUSIA 237
352 DECREASED ACTIVITY 236
353 EXPOSURE DURING PREGNANCY 236
354 HIATUS HERNIA 236
355 PNEUMONITIS 236
356 THERAPEUTIC RESPONSE UNEXPECTED 236
357 BLISTER 234
358 BLOOD PRESSURE ABNORMAL 234
359 GASTRIC DISORDER 232
360 MENTAL DISORDER 232
361 INTESTINAL OBSTRUCTION 231
362 DRUG DELIVERY SYSTEM ISSUE 230
363 NIGHTMARE 228
364 UPPER LIMB FRACTURE 227
365 BREAST CANCER 226
366 PULMONARY HYPERTENSION 226
367 SENSITIVITY TO WEATHER CHANGE 225
368 DERMATITIS ATOPIC 223
369 NEURALGIA 223
370 GASTROENTERITIS VIRAL 221
371 URINARY INCONTINENCE 221
372 COLITIS 220
373 ACUTE RESPIRATORY FAILURE 219
374 CARPAL TUNNEL SYNDROME 218
375 INTERSTITIAL LUNG DISEASE 218
376 PRODUCT DOSE OMISSION IN ERROR 218
377 URINARY RETENTION 217
378 INJURY 216
379 KIDNEY INFECTION 216
380 FOOT FRACTURE 215
381 MUSCULOSKELETAL CHEST PAIN 215
382 NIGHT SWEATS 213
383 RETCHING 212
384 PRESYNCOPE 211
385 THERAPEUTIC PRODUCT EFFECT DECREASED 211
386 GASTRITIS 210
387 PHARYNGITIS 209
388 HYPERSOMNIA 207
389 ANGINA PECTORIS 206
390 DRUG DEPENDENCE 206
391 DRUG EFFECT INCOMPLETE 205
392 END STAGE RENAL DISEASE 205
393 EXTRA DOSE ADMINISTERED 204
394 GAIT INABILITY 203
395 INABILITY TO AFFORD MEDICATION 203
396 INFUSION SITE PAIN 203
397 EAR PAIN 202
398 PANCREATITIS 202
399 DEMENTIA 201
400 INCREASED UPPER AIRWAY SECRETION 200
401 REVERSIBLE AIRWAYS OBSTRUCTION 200
402 INTERVERTEBRAL DISC PROTRUSION 198
403 POOR QUALITY SLEEP 198
404 THERAPEUTIC RESPONSE SHORTENED 198
405 OROPHARYNGEAL DISCOMFORT 196
406 SKIN DISCOLOURATION 196
407 HERNIA 195
408 MACULAR DEGENERATION 194
409 ANKLE FRACTURE 192
410 BRADYCARDIA 192
411 GOUT 192
412 MUSCULOSKELETAL DISCOMFORT 191
413 RASH MACULAR 191
414 INJECTION SITE REACTION 190
415 ACCIDENTAL EXPOSURE TO PRODUCT 189
416 INTENTIONAL DOSE OMISSION 189
417 DISORIENTATION 188
418 OBESITY 188
419 ALANINE AMINOTRANSFERASE INCREASED 186
420 GLOSSODYNIA 186
421 THROAT CLEARING 186
422 COLITIS ULCERATIVE 184
423 C-REACTIVE PROTEIN INCREASED 182
424 MALIGNANT NEOPLASM PROGRESSION 182
425 OSTEOPENIA 181
426 SPINAL FRACTURE 181
427 ACNE 179
428 COGNITIVE DISORDER 179
429 PAIN IN JAW 179
430 WEIGHT FLUCTUATION 179
431 BACK DISORDER 178
432 HYPOGLYCAEMIA 178
433 INCORRECT ROUTE OF DRUG ADMINISTRATION 178
434 SKIN DISORDER 178
435 CRYING 177
436 CYSTIC FIBROSIS 177
437 PHARYNGEAL OEDEMA 177
438 BLINDNESS 175
439 ANGER 174
440 RENAL INJURY 174
441 DYSSTASIA 172
442 FEEDING DISORDER 172
443 FEELING COLD 172
444 PERICARDIAL EFFUSION 172
445 ATELECTASIS 171
446 BLOOD GLUCOSE DECREASED 171
447 DEAFNESS 171
448 VASCULITIS 171
449 HYPOVENTILATION 170
450 INJECTION SITE HAEMORRHAGE 170
451 ORAL HERPES 170
452 PALLOR 170
453 COMA 169
454 HEAD DISCOMFORT 169
455 ACUTE MYOCARDIAL INFARCTION 168
456 DEVICE MISUSE 168
457 IRRITABLE BOWEL SYNDROME 168
458 ORAL DISCOMFORT 168
459 PRODUCT STORAGE ERROR 168
460 HAEMATURIA 167
461 LIVER DISORDER 167
462 PRODUCT SUBSTITUTION ISSUE 166
463 POLYP 165
464 RESTLESSNESS 165
465 DEVICE LEAKAGE 163
466 HYPERKALAEMIA 163
467 ANOSMIA 162
468 PANCYTOPENIA 162
469 TOXICITY TO VARIOUS AGENTS 162
470 EXPIRED PRODUCT ADMINISTERED 161
471 FEBRILE NEUTROPENIA 161
472 APHASIA 160
473 BODY TEMPERATURE INCREASED 160
474 HYPERGLYCAEMIA 160
475 PULMONARY THROMBOSIS 160
476 AGGRESSION 159
477 TOTAL LUNG CAPACITY DECREASED 159
478 PRODUCT ADMINISTRATION ERROR 158
479 ANAPHYLACTIC SHOCK 156
480 DEVICE BREAKAGE 156
481 INFUSION SITE ERYTHEMA 156
482 MOOD SWINGS 156
483 NEUTROPHIL COUNT INCREASED 156
484 TENDONITIS 155
485 WOUND 155
486 BLOOD SODIUM DECREASED 154
487 THYROID DISORDER 153
488 BLOOD IRON DECREASED 152
489 BONE DISORDER 152
490 BRONCHITIS CHRONIC 151
491 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 151
492 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 151
493 FEAR 151
494 FRUSTRATION TOLERANCE DECREASED 151
495 IMPAIRED HEALING 151
496 TASTE DISORDER 151
497 HYPOPHAGIA 150
498 CLOSTRIDIUM DIFFICILE INFECTION 149
499 DIPLOPIA 149
500 IMMUNE SYSTEM DISORDER 149
501 DEVICE USE ERROR 148
502 PHARYNGITIS STREPTOCOCCAL 148
503 PRODUCT PRESCRIBING ERROR 148
504 ACTIVITIES OF DAILY LIVING IMPAIRED 147
505 FAECES DISCOLOURED 147
506 MOVEMENT DISORDER 147
507 BENIGN PROSTATIC HYPERPLASIA 146
508 DYSARTHRIA 146
509 EAR DISCOMFORT 146
510 POST PROCEDURAL COMPLICATION 146
511 PULMONARY FUNCTION TEST ABNORMAL 145
512 CONJUNCTIVITIS 144
513 PULMONARY ARTERIAL HYPERTENSION 144
514 INTERNATIONAL NORMALISED RATIO INCREASED 143
515 RESPIRATORY SYNCYTIAL VIRUS INFECTION 143
516 THERAPY NON-RESPONDER 143
517 TOOTH DISORDER 143
518 CONVULSION 141
519 LOWER LIMB FRACTURE 140
520 PHARYNGEAL SWELLING 140
521 ASPARTATE AMINOTRANSFERASE INCREASED 139
522 INFUSION SITE SWELLING 139
523 PARAESTHESIA ORAL 139
524 VITAMIN D DEFICIENCY 139
525 DRUG ADMINISTRATION ERROR 138
526 FOETAL EXPOSURE DURING PREGNANCY 138
527 HYPERLIPIDAEMIA 137
528 PNEUMONIA ASPIRATION 137
529 MICTURITION URGENCY 136
530 SEPTIC SHOCK 136
531 TOOTH ABSCESS 136
532 DYSKINESIA 135
533 ELECTROCARDIOGRAM QT PROLONGED 135
534 NEPHROGENIC ANAEMIA 135
535 OFF LABEL USE OF DEVICE 135
536 NASAL OBSTRUCTION 134
537 SENSATION OF FOREIGN BODY 134
538 SUICIDE ATTEMPT 134
539 ADRENAL INSUFFICIENCY 133
540 SCIATICA 133
541 TOOTH INFECTION 133
542 ASPIRATION 132
543 FOOD ALLERGY 132
544 HEPATIC STEATOSIS 132
545 PROCEDURAL PAIN 132
546 RESTLESS LEGS SYNDROME 132
547 BLOOD URINE PRESENT 131
548 INJECTION SITE RASH 131
549 TOOTHACHE 131
550 ABNORMAL BEHAVIOUR 130
551 HAEMORRHOIDS 129
552 RHABDOMYOLYSIS 129
553 TENDON RUPTURE 129
554 ACCIDENT 128
555 COVID-19 PNEUMONIA 128
556 PRODUCT AVAILABILITY ISSUE 128
557 FREQUENT BOWEL MOVEMENTS 127
558 PRURITUS GENERALISED 127
559 RED BLOOD CELL COUNT DECREASED 127
560 ANHEDONIA 126
561 DYSPNOEA AT REST 126
562 EOSINOPHIL COUNT ABNORMAL 126
563 FACE OEDEMA 126
564 THIRST 126
565 WRIST FRACTURE 126
566 SKIN IRRITATION 125
567 CARDIAC MURMUR 124
568 HYPERCHOLESTEROLAEMIA 124
569 JOINT STIFFNESS 124
570 SNORING 124
571 ABASIA 123
572 EATING DISORDER 123
573 LOWER RESPIRATORY TRACT CONGESTION 123
574 MASS 123
575 PNEUMONIA BACTERIAL 123
576 PROSTATE CANCER 123
577 SKIN ULCER 123
578 RESPIRATORY SYMPTOM 122
579 SKIN LACERATION 122
580 HAEMATEMESIS 121
581 INJECTION SITE MASS 121
582 LIGAMENT SPRAIN 121
583 SKIN BURNING SENSATION 121
584 ABNORMAL DREAMS 120
585 CHROMATURIA 120
586 FORCED VITAL CAPACITY DECREASED 120
587 TREATMENT FAILURE 120
588 WRONG TECHNIQUE IN DRUG USAGE PROCESS 120
589 ASPHYXIA 119
590 BRONCHIAL DISORDER 119
591 PLATELET COUNT INCREASED 119
592 THINKING ABNORMAL 119
593 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 118
594 CORONARY ARTERY OCCLUSION 118
595 RENAL FAILURE ACUTE 118
596 DELIRIUM 117
597 EYE INFECTION 117
598 MENTAL IMPAIRMENT 117
599 PSORIATIC ARTHROPATHY 117
600 DRUG DELIVERY SYSTEM MALFUNCTION 116
601 IMPAIRED WORK ABILITY 116
602 PHOTOPHOBIA 116
603 QUALITY OF LIFE DECREASED 116
604 WITHDRAWAL SYNDROME 116
605 BACK INJURY 115
606 INCREASED BRONCHIAL SECRETION 115
607 RENAL CYST 115
608 ROTATOR CUFF SYNDROME 115
609 BURSITIS 114
610 CARDIO-RESPIRATORY ARREST 114
611 COLD SWEAT 114
612 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 114
613 EXERCISE TOLERANCE DECREASED 114
614 MOUTH ULCERATION 114
615 DRUG PRESCRIBING ERROR 113
616 KNEE ARTHROPLASTY 113
617 PRE-EXISTING CONDITION IMPROVED 113
618 ALLERGY TO ANIMAL 112
619 EXPOSURE VIA SKIN CONTACT 112
620 HEPATIC CIRRHOSIS 112
621 LUNG OPACITY 112
622 SARS-COV-2 TEST POSITIVE 112
623 SPUTUM INCREASED 112
624 SYSTEMIC LUPUS ERYTHEMATOSUS 112
625 BONE DENSITY DECREASED 111
626 CHOKING SENSATION 111
627 HAEMATOCRIT DECREASED 111
628 HYPOKINESIA 111
629 PRODUCT DISPENSING ERROR 111
630 HYPERVENTILATION 110
631 BLOOD PRESSURE DIASTOLIC DECREASED 109
632 BRONCHIAL SECRETION RETENTION 109
633 CYANOSIS 109
634 MULTIPLE SCLEROSIS RELAPSE 109
635 RASH GENERALISED 109
636 UPPER GASTROINTESTINAL HAEMORRHAGE 109
637 DERMATITIS ALLERGIC 108
638 GALLBLADDER DISORDER 108
639 HEARING IMPAIRED 108
640 IMPAIRED GASTRIC EMPTYING 108
641 INCREASED TENDENCY TO BRUISE 108
642 INTERVERTEBRAL DISC DEGENERATION 108
643 ORTHOSTATIC HYPOTENSION 108
644 RHONCHI 108
645 CEREBRAL HAEMORRHAGE 107
646 PRODUCT COMPLAINT 107
647 DERMATITIS CONTACT 106
648 DRUG EFFECT LESS THAN EXPECTED 106
649 EMOTIONAL DISORDER 106
650 IMMUNODEFICIENCY 106
651 LUNG HYPERINFLATION 106
652 OCULAR DISCOMFORT 106
653 RESPIRATORY ARREST 106
654 SINUS PAIN 106
655 UNRESPONSIVE TO STIMULI 106
656 BIPOLAR DISORDER 105
657 MELAENA 105
658 OBSTRUCTION 105
659 OVERWEIGHT 105
660 ASCITES 104
661 BLINDNESS UNILATERAL 104
662 BLOOD GLUCOSE ABNORMAL 104
663 MOOD ALTERED 104
664 MUSCLE TWITCHING 104
665 OSTEONECROSIS 104
666 PARKINSON^S DISEASE 104
667 SARCOIDOSIS 104
668 LIVER FUNCTION TEST INCREASED 103
669 PSYCHOMOTOR HYPERACTIVITY 103
670 DRUG DISPENSING ERROR 102
671 SKIN FISSURES 102
672 VOCAL CORD DISORDER 102
673 NASAL DISCHARGE DISCOLOURATION 101
674 PRODUCT PHYSICAL ISSUE 101
675 SUPRAVENTRICULAR TACHYCARDIA 101
676 ABORTION SPONTANEOUS 100
677 MULTIPLE SCLEROSIS 100
678 NASAL DISCOMFORT 100
679 PARANASAL SINUS DISCOMFORT 100
680 VAGINAL HAEMORRHAGE 100
681 ABNORMAL LOSS OF WEIGHT 99
682 DUST ALLERGY 99
683 LEUKOPENIA 99
684 OXYGEN SATURATION ABNORMAL 99
685 REBOUND ACID HYPERSECRETION 99
686 SCAR 99
687 VITAL CAPACITY DECREASED 99
688 BRAIN FOG 98
689 DRUG WITHDRAWAL SYNDROME 98
690 FLUID OVERLOAD 98
691 LACTIC ACIDOSIS 98
692 LOCAL SWELLING 98
693 LYMPHOMA 98
694 SPINAL OSTEOARTHRITIS 98
695 BLOOD ALKALINE PHOSPHATASE INCREASED 97
696 BLOOD CREATINE PHOSPHOKINASE INCREASED 97
697 FEMUR FRACTURE 96
698 GLYCOSYLATED HAEMOGLOBIN INCREASED 96
699 PANCREATITIS ACUTE 96
700 PNEUMONIA VIRAL 96
701 PSEUDOMONAS INFECTION 96
702 BRONCHIAL WALL THICKENING 95
703 HEPATIC FUNCTION ABNORMAL 95
704 TEMPERATURE INTOLERANCE 95
705 TUBULOINTERSTITIAL NEPHRITIS 95
706 ABDOMINAL PAIN LOWER 94
707 CARDIOMEGALY 94
708 CONCUSSION 94
709 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 94
710 LIVER FUNCTION TEST ABNORMAL 94
711 NERVE COMPRESSION 94
712 RESTRICTIVE PULMONARY DISEASE 94
713 BRONCHIAL HYPERREACTIVITY 93
714 PANIC REACTION 93
715 DERMATITIS 92
716 GASTROENTERITIS 92
717 HYPOAESTHESIA ORAL 92
718 INFUSION SITE HAEMORRHAGE 92
719 METABOLIC ACIDOSIS 92
720 TOOTH LOSS 92
721 ULCER 92
722 BLOOD CALCIUM INCREASED 91
723 BLOOD POTASSIUM INCREASED 91
724 GLUCOSE TOLERANCE IMPAIRED 91
725 MUSCLE TIGHTNESS 91
726 TONGUE DISORDER 91
727 AFFECTIVE DISORDER 90
728 CHEST X-RAY ABNORMAL 90
729 FULL BLOOD COUNT DECREASED 90
730 GASTRIC ULCER 90
731 HEREDITARY ANGIOEDEMA 90
732 INJECTION SITE URTICARIA 90
733 SKIN INFECTION 90
734 TRANSAMINASES INCREASED 90
735 ACCIDENTAL OVERDOSE 89
736 JOINT DISLOCATION 89
737 LARYNGEAL STENOSIS 89
738 SCAB 89
739 SINUS TACHYCARDIA 89
740 SKIN CANCER 89
741 BASAL CELL CARCINOMA 88
742 COLON CANCER 88
743 CONGENITAL HIATUS HERNIA 88
744 CYST 88
745 MUSCLE STRAIN 88
746 PRODUCT ADMINISTRATION INTERRUPTED 88
747 SKIN HAEMORRHAGE 88
748 TONGUE DISCOLOURATION 88
749 AORTIC ANEURYSM 87
750 INJURY ASSOCIATED WITH DEVICE 87
751 MUSCULOSKELETAL DISORDER 87
752 NASAL DISORDER 87
753 PULMONARY PAIN 87
754 BLOOD MAGNESIUM DECREASED 86
755 GENERALISED OEDEMA 86
756 NEEDLE ISSUE 86
757 PRODUCT PRESCRIBING ISSUE 86
758 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 86
759 AGRANULOCYTOSIS 85
760 DISABILITY 85
761 FRACTURE 85
762 NERVOUS SYSTEM DISORDER 85
763 OBSTRUCTIVE SLEEP APNOEA SYNDROME 85
764 ORAL DISORDER 85
765 ARTERIOSCLEROSIS 84
766 CANDIDIASIS 84
767 CREPITATIONS 84
768 ESSENTIAL HYPERTENSION 84
769 LABORATORY TEST ABNORMAL 84
770 LEUKOCYTOSIS 84
771 LIP INJURY 84
772 LUNG CONSOLIDATION 84
773 MALIGNANT MELANOMA 84
774 NEUTROPHIL COUNT DECREASED 84
775 PLASMA CELL MYELOMA 84
776 VIRAL UPPER RESPIRATORY TRACT INFECTION 84
777 DENTAL CARIES 83
778 EPILEPSY 83
779 HYPOCALCAEMIA 83
780 INCREASED APPETITE 83
781 POOR VENOUS ACCESS 83
782 PRESCRIBED OVERDOSE 83
783 UPPER RESPIRATORY TRACT CONGESTION 83
784 DEPRESSED LEVEL OF CONSCIOUSNESS 82
785 GASTROINTESTINAL INFECTION 82
786 HEPATITIS 82
787 ARTHROPOD BITE 81
788 CHOLECYSTECTOMY 81
789 CONTRAINDICATED PRODUCT ADMINISTERED 81
790 DIABETES MELLITUS INADEQUATE CONTROL 81
791 ERUCTATION 81
792 NOCTURIA 81
793 NOCTURNAL DYSPNOEA 81
794 PARANOIA 81
795 PROSTATOMEGALY 81
796 BLOOD PRESSURE DIASTOLIC INCREASED 80
797 GLOMERULAR FILTRATION RATE DECREASED 80
798 INFUSION SITE PRURITUS 80
799 NEPHROPATHY 80
800 TUBERCULOSIS 80
801 ASPERGILLUS INFECTION 79
802 BLOOD BILIRUBIN INCREASED 79
803 BLOOD CHOLESTEROL ABNORMAL 79
804 DEVICE DIFFICULT TO USE 79
805 INTERNAL HAEMORRHAGE 79
806 JAUNDICE 79
807 NODULE 79
808 PHOTOSENSITIVITY REACTION 79
809 PSYCHOTIC DISORDER 79
810 RASH MACULO-PAPULAR 79
811 FACIAL PAIN 78
812 HIP ARTHROPLASTY 78
813 INCORRECT PRODUCT ADMINISTRATION DURATION 78
814 RIGHT VENTRICULAR FAILURE 78
815 ARTERIAL OCCLUSIVE DISEASE 77
816 BRONCHIOLITIS 77
817 ERECTILE DYSFUNCTION 77
818 GLOSSITIS 77
819 GRANULOMA 77
820 HYPERTHYROIDISM 77
821 INFUSION SITE BRUISING 77
822 LOWER GASTROINTESTINAL HAEMORRHAGE 77
823 NERVE INJURY 77
824 POOR QUALITY DEVICE USED 77
825 RASH PAPULAR 77
826 VITAMIN D DECREASED 77
827 DEVICE INEFFECTIVE 76
828 GAMMA-GLUTAMYLTRANSFERASE INCREASED 76
829 LYMPHOCYTE COUNT DECREASED 76
830 SPINAL DISORDER 76
831 SPUTUM RETENTION 76
832 BLADDER DISORDER 75
833 BREAST CANCER FEMALE 75
834 BRONCHIAL OBSTRUCTION 75
835 ENCEPHALOPATHY 75
836 MYOCARDIAL ISCHAEMIA 75
837 PRODUCT DISTRIBUTION ISSUE 75
838 SINUS HEADACHE 75
839 SKIN PLAQUE 75
840 SMALL INTESTINAL OBSTRUCTION 75
841 VOCAL CORD DYSFUNCTION 75
842 CARDIOVASCULAR DISORDER 74
843 DIVERTICULUM 74
844 EAR PRURITUS 74
845 MITRAL VALVE INCOMPETENCE 74
846 ORAL MUCOSAL BLISTERING 74
847 OSTEOMYELITIS 74
848 PLEURISY 74
849 SCOLIOSIS 74
850 TENDON PAIN 74
851 THERAPY CHANGE 74
852 TOTAL LUNG CAPACITY INCREASED 74
853 CIRCULATORY COLLAPSE 73
854 HALLUCINATION, VISUAL 73
855 INFUSION SITE EXTRAVASATION 73
856 IRON DEFICIENCY 73
857 ISCHAEMIC STROKE 73
858 PAIN OF SKIN 73
859 POLYCYSTIC OVARIES 73
860 POLYNEUROPATHY 73
861 PRODUCT USE COMPLAINT 73
862 SCRATCH 73
863 STENT PLACEMENT 73
864 ECCHYMOSIS 72
865 GROIN PAIN 72
866 OESOPHAGEAL CANDIDIASIS 72
867 POST PROCEDURAL INFECTION 72
868 SKIN ATROPHY 72
869 BEDRIDDEN 71
870 CARDIOMYOPATHY 71
871 ECONOMIC PROBLEM 71
872 EYE HAEMORRHAGE 71
873 HEPATIC FAILURE 71
874 IRON DEFICIENCY ANAEMIA 71
875 PAROSMIA 71
876 RED CELL DISTRIBUTION WIDTH INCREASED 71
877 SYMPTOM RECURRENCE 71
878 ARTERIOSCLEROSIS CORONARY ARTERY 70
879 BLOOD UREA INCREASED 70
880 MYCOBACTERIUM AVIUM COMPLEX INFECTION 70
881 RESPIRATORY GAS EXCHANGE DISORDER 70
882 RESPIRATORY TRACT INFLAMMATION 70
883 BRAIN INJURY 69
884 DIZZINESS POSTURAL 69
885 GASTROINTESTINAL PAIN 69
886 GENERAL PHYSICAL CONDITION ABNORMAL 69
887 HYSTERECTOMY 69
888 MENTAL STATUS CHANGES 69
889 OSTEONECROSIS OF JAW 69
890 SENSITISATION 69
891 SENSORY DISTURBANCE 69
892 SPINAL COMPRESSION FRACTURE 69
893 TOOTH FRACTURE 69
894 INTRAOCULAR PRESSURE INCREASED 68
895 PERIPHERAL COLDNESS 68
896 VENTRICULAR EXTRASYSTOLES 68
897 HYPERPARATHYROIDISM SECONDARY 67
898 PRODUCT PACKAGING ISSUE 67
899 RENAL TUBULAR NECROSIS 67
900 SPINAL PAIN 67
901 UMBILICAL HERNIA 67
902 DRUG ABUSE 66
903 FLANK PAIN 66
904 HUNGER 66
905 ORTHOPNOEA 66
906 TERMINAL INSOMNIA 66
907 TONGUE DISCOMFORT 66
908 WOUND INFECTION 66
909 AUTOIMMUNE DISORDER 65
910 BREAST PAIN 65
911 DEVICE RELATED INFECTION 65
912 DRUG ERUPTION 65
913 HAND FRACTURE 65
914 PEAK EXPIRATORY FLOW RATE DECREASED 65
915 SUFFOCATION FEELING 65
916 TENDON DISORDER 65
917 ATRIAL FLUTTER 64
918 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 64
919 COAGULOPATHY 64
920 EYE DISCHARGE 64
921 HYPOMAGNESAEMIA 64
922 INTENTIONAL OVERDOSE 64
923 MUSCLE ATROPHY 64
924 ORAL FUNGAL INFECTION 64
925 PARALYSIS 64
926 RENAL PAIN 64
927 TACHYPNOEA 64
928 TROPONIN INCREASED 64
929 ANEURYSM 63
930 APPARENT DEATH 63
931 GOITRE 63
932 INITIAL INSOMNIA 63
933 LEUKAEMIA 63
934 LUNG INFILTRATION 63
935 NASAL DRYNESS 63
936 NASAL SEPTUM DEVIATION 63
937 DEVICE DISLOCATION 62
938 DRUG LEVEL INCREASED 62
939 ELECTROLYTE IMBALANCE 62
940 GENERALISED TONIC-CLONIC SEIZURE 62
941 HYPOPNOEA 62
942 INJECTION SITE DISCOMFORT 62
943 KYPHOSIS 62
944 MYCOTIC ALLERGY 62
945 SHOCK 62
946 SPINAL OPERATION 62
947 BLOOD LACTIC ACID INCREASED 61
948 GINGIVAL PAIN 61
949 HEPATOCELLULAR INJURY 61
950 INTENTIONAL DEVICE USE ISSUE 61
951 JOINT RANGE OF MOTION DECREASED 61
952 MUSCLE DISORDER 61
953 RESPIRATORY TRACT INFECTION VIRAL 61
954 BLOOD TRIGLYCERIDES INCREASED 60
955 BUNDLE BRANCH BLOCK LEFT 60
956 CARDIAC FAILURE CHRONIC 60
957 DRUG-INDUCED LIVER INJURY 60
958 EAR DISORDER 60
959 EXOSTOSIS 60
960 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 60
961 PULMONARY HAEMORRHAGE 60
962 SKIN ABRASION 60
963 ATRIOVENTRICULAR BLOCK 59
964 INCORRECT DRUG ADMINISTRATION RATE 59
965 MALIGNANT MELANOMA IN SITU 59
966 MANIA 59
967 PERFUME SENSITIVITY 59
968 PRODUCT ODOUR ABNORMAL 59
969 RHINOVIRUS INFECTION 59
970 ANKYLOSING SPONDYLITIS 58
971 BREAST MASS 58
972 CARDIAC FLUTTER 58
973 DRUG EXPOSURE DURING PREGNANCY 58
974 INCONTINENCE 58
975 OESOPHAGEAL DISORDER 58
976 PELVIC PAIN 58
977 POLYMYALGIA RHEUMATICA 58
978 PROSTATIC DISORDER 58
979 PURPURA 58
980 STEVENS-JOHNSON SYNDROME 58
981 VITREOUS FLOATERS 58
982 ANGIOPATHY 57
983 CARDIAC VALVE DISEASE 57
984 INGUINAL HERNIA 57
985 NEOPLASM PROGRESSION 57
986 POST-TRAUMATIC STRESS DISORDER 57
987 RESPIRATORY RATE DECREASED 57
988 SLUGGISHNESS 57
989 TOOTH EXTRACTION 57
990 ANAL INCONTINENCE 56
991 COMPLICATION ASSOCIATED WITH DEVICE 56
992 DIARRHOEA HAEMORRHAGIC 56
993 IMPAIRED DRIVING ABILITY 56
994 MYCOBACTERIAL INFECTION 56
995 PELVIC FRACTURE 56
996 POSTOPERATIVE WOUND INFECTION 56
997 PRODUCT LABEL ISSUE 56
998 PROTEINURIA 56
999 RED BLOOD CELL SEDIMENTATION RATE INCREASED 56